Adenoviral Delivery of CRISPR/Cas9 Aims to Expand Genome Editing to Primary Cells
Type
Blog Post
Published
Dec. 10, 2020, 1 p.m.
...vast majority of AdV-modified human cells being subjected to scarless homology-directed genome editing (...